EANS-Adhoc: LifeWatch AG
Offenlegung von Beteiligungen gemäss Artikel 9 in
Verbindung mit Artikel 21 Börsenverordnung-FINMA
-------------------------------------------------------------------------------- Ad-hoc-Mitteilung übermittelt durch euro adhoc mit dem Ziel einer europaweiten Verbreitung. Für den Inhalt ist der Emittent verantwortlich. --------------------------------------------------------------------------------
Vorstand/Stellungnahmen/LifeWatch AG Offenlegungsmitteilung
02.05.2011
Neuhausen am Rheinfall / Schweiz - LifeWatch AG (SIX Swiss Exchange: LIFE), gibt heute bekannt, dass gemäss einer 28. April 2011 unterzeichneten Mitteilung die Federated Equity Management Company, 1001 Liberty Avenue, Pittsburgh, Pennsylvania 15222 (Kontakt: Todd Gibson/Tel. +1 412 288 7403) indirekt und über den Federated Kaufmann Fund, 4000 Ericsson Drive, Warrendale, Pennsylvania 15086-7561, seit einem am 21. Januar 2011 resp. am 25. Januar 2011 erfolgten Kauf mit 646'125 Namenaktien 4.93% der Stimmrechte an der LifeWatch AG hält. Mit 600'000 Namenaktien entfallen allein 4.58% auf den Federated Kaufmann Fund.
Die Federated Equity Management Copmany wird von John F. Donahue, Rhodora Donahue und J. Christopher Donahue, c/o The Beachwood Company, 1001 Liberty Avenue, Pittsburgh, Pennsylvania 15222, kontrolliert, die Treuhänder des Voting Shares Irrevocable Trust mit derselben Postanschrift sind. Der Voting Shares Irrevocable Trust besitzt alle Anteile an der Federated Investors Inc., der alleinigen und endgültigen Muttergesellschaft von Federated Equity Management Company. Die wirtschaftlich berechtigten Eigentümer der LifeWatch-Aktien sind verschiedene Fonds, die von Federated Equity Management Company gemanagt werden.
Zu LifeWatch AG:
LifeWatch AG, mit Hauptsitz in Neuhausen am Rheinfall und Kotierung an der SIX Swiss Exchange (LIFE) in der Schweiz, ist der führende Anbieter moderner Telemedizinsysteme und Überwachungsdienstleistungen (Monitoring Services) für Personengruppen, die von Hochrisikopatienten und chronisch Kranken bis zu normalen Konsumenten von Gesundheits- und Wellnessprodukten reichen. LifeWatch verfügt über Niederlassungen in den USA, den Niederlanden, Japan, Grossbritannien, der Schweiz und in Israel. LifeWatch AG ist die Muttergesellschaft von LifeWatch Services, Inc., einem Unternehmen für Überwachungsdienstleistungen insbesondere bei Herzerkrankungen - Cardiac Monitoring Services - und Hersteller von Telekardiologie-Produkten. LifeWatch führt unter dem Markenname NiteWatch eines neues Programm zur Schlafanalyse für zu Hause für Patienten mit Obstruktivem Schlafapnoe-Syndrom ein. Für weitere Informationen siehe www.lifewatch.com and www.nitewatchservices.com.
E-Mail Alerts: Um regelmässig die neusten Informationen zu LifeWatch zu erhalten, tragen Sie sich bitte in die Verteilerliste ein unter http://production.investis.com/lifewatch/alert-service/
This press release includes forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding future results of operations and financial position, business strategy and plans and objectives for future operations, are forward- looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect" and similar expressions are intended to identify forward-looking statements. LifeWatch AG has based these forward looking statements largely on current expectations and projections about future events and financial trends that it believes may affect the financial condition, results of operations, business strategy, short term and long term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances described may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward- looking statements. All forward-looking statements are based only on data available to LifeWatch AG at the time of the issue of this press release. LifeWatch AG does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS OF THE ISSUER.
Ende der Mitteilung euro adhoc --------------------------------------------------------------------------------
Kontakt:
Sensus Investor & Public Relations, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12
Email lifewatch@sensus.ch
Branche: Gesundheitsdienste
ISIN: CH0012815459
WKN: 1281545
Index: SPI, SPIEX
Börsen: Frankfurt / Open Market (Freiverkehr) / XETRA
Berlin / Freiverkehr
SIX Swiss Exchange / Main Standard